menu
European Commission
This project has received funding from the
European Union’s Seventh Framework Programme
for research, technological development and demonstration.
agence de communication Lyon
menu

    TumAdoR PROJECT

    Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context

    Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising

    Events
    News

    24 July 2014 M12 project meeting in Turku

    The University of Turku organizes the third project meeting of TumAdoR on 25-26th August 2014 (see agenda here).More >>


    Displaying results 7 to 7 out of 7
    Brochure